Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Halozyme Therapeutics Inc (HALO)  
$44.29 0.94 (2.17%) as of 4:30 Fri 5/31


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 137,030,000
Market Cap: 6.07(B)
Last Volume: 1,182,236 Avg Vol: 1,218,005
52 Week Range: $32.49 - $45.82
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  466
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Halozyme Therapeutics is a biopharma technology platform company that provides solutions to improve patient experience and outcomes. Co.'s approved product and its collaborators' approved products and product candidates are based on rHuPH20, its patented recombinant human hyaluronidase enzyme. Co. refers to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as its ENHANZE® drug delivery technology (ENHANZE). Co. licenses the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 60,000 120,000 300,000 584,448
Total Sell Value $2,512,970 $4,828,155 $12,314,195 $26,911,596
Total People Sold 1 1 3 6
Total Sell Transactions 6 12 30 61
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 839
  Page 25 of 34  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kirk Randal J Director   –       •       •   2008-05-08 4 A $0.00 $0 D/D 15,000 370,000     -
   Patton John Stuart Director   –       •      –    2008-05-08 4 A $4.94 $74,100 D/D 15,000 30,000     -
   Thornton Steven T Director   –       •      –    2008-05-08 4 A $4.94 $74,100 D/D 15,000 30,000     -
   Engler Robert L Md Director   –       •      –    2008-05-08 4 A $4.94 $74,100 D/D 15,000 55,000     -
   Matsui Connie Director   –       •      –    2008-05-08 4 A $4.94 $74,100 D/D 15,000 45,000     -
   Falberg Kathryn E Director   –       •      –    2008-05-08 4 A $4.94 $74,100 D/D 15,000 30,000     -
   Kelley Kenneth J Director   –       •      –    2008-05-08 4 A $4.94 $74,100 D/D 15,000 30,000     -
   Kirk Randal J Director   –       •       •   2008-03-20 4 B $6.06 $7,704,901 I/I 1,264,657 6,328,853 2.25     -
   Little Robert J VP, Chief Commercial Officer   •       –      –    2008-03-20 4 B $5.96 $53,754 D/D 9,000 13,000 2.74     -
   Lim Jonathan E President, CEO   •       •      –    2008-03-20 4 S $6.06 $1,515,000 D/D (250,000) 680,000     -
   Frost Gregory Ian VP and Chief Scientific Off.   •       •      –    2008-03-20 4 S $6.06 $1,393,800 D/D (230,000) 3,530,866     -
   Lim Jonathan E President, CEO   •       •      –    2008-03-19 4 OE $0.39 $89,700 D/D 230,000 930,000     -
   Frost Gregory Ian VP and Chief Scientific Off.   •       •      –    2008-03-19 4 D $6.06 $173,571 D/D (28,642) 3,760,866     -
   Frost Gregory Ian VP and Chief Scientific Off.   •       •      –    2008-03-19 4 OE $0.43 $275,158 D/D 639,902 3,789,508     -
   Kirk Randal J Director   –       •       •   2008-03-19 4 B $5.80 $5,142,570 I/I 886,650 5,064,196 2.25     -
   Ramsay David A Secretary, CFO   •       –      –    2008-03-18 4 B $4.50 $45,565 D/D 10,000 411,410 2.74     -
   Kirk Randal J Director   –       •       •   2008-03-18 4 B $4.57 $948,485 I/I 207,546 4,177,546 2.25     -
   Frost Gregory Ian VP and Chief Scientific Off.   •       •      –    2007-12-20 4 AS $7.00 $63,959 D/D (9,137) 3,149,606     -
   Frost Gregory Ian VP and Chief Scientific Off.   •       •      –    2007-12-20 4 D $6.98 $4,181 D/D (599) 3,158,743     -
   Frost Gregory Ian VP and Chief Scientific Off.   •       •      –    2007-12-20 4 OE $0.43 $4,186 D/D 9,736 3,159,342     -
   Frost Gregory Ian VP and Chief Scientific Off.   •       •      –    2007-12-11 4 D $6.66 $18,382 D/D (2,760) 3,149,606     -
   Frost Gregory Ian VP and Chief Scientific Off.   •       •      –    2007-12-11 4 OE $0.43 $18,387 D/D 42,760 3,152,366     -
   Lim Jonathan E President, CEO   •       •      –    2007-11-30 4 AS $8.06 $164,796 D/D (20,000) 700,000     -
   Lim Jonathan E President, CEO   •       •      –    2007-11-30 4 OE $0.39 $7,800 D/D 20,000 720,000     -
   Frost Gregory Ian VP and Chief Scientific Off.   •       •      –    2007-11-21 4 AS $7.51 $76,246 D/D (10,000) 3,109,606     -
  839 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 25 of 34
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us